Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signaling.

Bachmann B, Spitz S, Rothbauer M, Jordan C, Purtscher M, Zirath H, Schuller P, Eilenberger C, Ali SF, Mühleder S, Priglinger E, Harasek M, Redl H, Holnthoner W, Ertl P.

Biomicrofluidics. 2018 Jun 20;12(4):042216. doi: 10.1063/1.5027054. eCollection 2018 Jul.

2.

Monitoring cellular stress responses using integrated high-frequency impedance spectroscopy and time-resolved ELISA.

Charwat V, Joksch M, Sticker D, Purtscher M, Rothbauer M, Ertl P.

Analyst. 2014 Oct 21;139(20):5271-82. doi: 10.1039/c4an00824c. Epub 2014 Aug 19.

PMID:
25137192
3.

Standardization of microfluidic cell cultures using integrated organic photodiodes and electrode arrays.

Charwat V, Purtscher M, Tedde SF, Hayden O, Ertl P.

Lab Chip. 2013 Mar 7;13(5):785-97. doi: 10.1039/c2lc40965h. Epub 2012 Dec 19.

PMID:
23254868
4.

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Turecek PL, Bossard MJ, Graninger M, Gritsch H, Höllriegl W, Kaliwoda M, Matthiessen P, Mitterer A, Muchitsch EM, Purtscher M, Rottensteiner H, Schiviz A, Schrenk G, Siekmann J, Varadi K, Riley T, Ehrlich HJ, Schwarz HP, Scheiflinger F.

Hamostaseologie. 2012;32 Suppl 1:S29-38.

PMID:
22961422
5.

Magnetoresistive-based real-time cell phagocytosis monitoring.

Shoshi A, Schotter J, Schroeder P, Milnera M, Ertl P, Charwat V, Purtscher M, Heer R, Eggeling M, Reiss G, Brueckl H.

Biosens Bioelectron. 2012 Jun-Jul;36(1):116-22. doi: 10.1016/j.bios.2012.04.002. Epub 2012 Apr 20.

PMID:
22560105
6.

Development of a plasma- and albumin-free recombinant von Willebrand factor.

Turecek PL, Mitterer A, Matthiessen HP, Gritsch H, Varadi K, Siekmann J, Schnecker K, Plaimauer B, Kaliwoda M, Purtscher M, Woehrer W, Mundt W, Muchitsch EM, Suiter T, Ewenstein B, Ehrlich HJ, Schwarz HP.

Hamostaseologie. 2009 Oct;29 Suppl 1:S32-8.

PMID:
19763356
7.

Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes.

Semlitsch T, Tillian HM, Zarkovic N, Borovic S, Purtscher M, Hohenwarter O, Schaur RJ.

Anticancer Res. 2002 May-Jun;22(3):1689-97.

PMID:
12168855
8.

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F, Katinger H.

AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1757-65.

PMID:
11788027
9.

Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells.

Kunert R, Steinfellner W, Purtscher M, Assadian A, Katinger H.

Biotechnol Bioeng. 2000 Jan 5;67(1):97-103.

PMID:
10581440
10.

Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.

Parren PW, Wang M, Trkola A, Binley JM, Purtscher M, Katinger H, Moore JP, Burton DR.

J Virol. 1998 Dec;72(12):10270-4.

11.

A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples.

Steindl F, Armbruster C, Pierer K, Purtscher M, Katinger HW.

J Immunol Methods. 1998 Aug 1;217(1-2):143-51.

PMID:
9776584
12.

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

Eckhart L, Raffelsberger W, Ferko B, Klima A, Purtscher M, Katinger H, Rüker F.

J Gen Virol. 1996 Sep;77 ( Pt 9):2001-8.

PMID:
8810996
13.

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5.

Purtscher M, Trkola A, Grassauer A, Schulz PM, Klima A, Döpper S, Gruber G, Buchacher A, Muster T, Katinger H.

AIDS. 1996 Jun;10(6):587-93.

PMID:
8780812
14.

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.

Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H.

J Virol. 1996 Feb;70(2):1100-8.

15.

Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Muster T, Ferko B, Klima A, Purtscher M, Trkola A, Schulz P, Grassauer A, Engelhardt OG, García-Sástre A, Palese P, et al.

J Virol. 1995 Nov;69(11):6678-86.

16.

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A, et al.

AIDS Res Hum Retroviruses. 1994 Dec;10(12):1651-8.

PMID:
7888224
17.

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, Katinger H.

J Virol. 1994 Jun;68(6):4031-4.

18.

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.

Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, et al.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):359-69.

PMID:
7520721
19.

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.

Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Rüker F, Katinger H.

J Virol. 1993 Nov;67(11):6642-7.

20.

Isolation of isoproteins from monoclonal antibodies and recombinant proteins by chromatofocusing.

Jungbauer A, Tauer C, Wenisch E, Uhl K, Brunner J, Purtscher M, Steindl F, Buchacher A.

J Chromatogr. 1990 Jul 20;512:157-63.

PMID:
2229225
21.

Comparison of protein A, protein G and copolymerized hydroxyapatite for the purification of human monoclonal antibodies.

Jungbauer A, Tauer C, Reiter M, Purtscher M, Wenisch E, Steindl F, Buchacher A, Katinger H.

J Chromatogr. 1989 Aug 4;476:257-68.

PMID:
2777978
22.

Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1.

Jungbauer A, Tauer C, Wenisch E, Steindl F, Purtscher M, Reiter M, Unterluggauer F, Buchacher A, Uhl K, Katinger H.

J Biochem Biophys Methods. 1989 Aug-Sep;19(2-3):223-40.

PMID:
2584609

Supplemental Content

Loading ...
Support Center